Latent profile analysis of self-management and its association with quality of life differences in patients with cancer treated with immune checkpoint inhibitors
Ruiqi Lu, Zhihui Yang, Jingxia Miao, Qian Xu, Lili Zhang

TL;DR
This study identifies three self-management profiles in cancer patients using immune checkpoint inhibitors and links them to quality of life differences.
Contribution
The study introduces a novel latent profile analysis of self-management in cancer patients receiving immune checkpoint inhibitors.
Findings
Three self-management profiles were identified: low, average with information avoidance, and high self-management.
Coping modes, education, insurance, age, income, and communication styles influence self-management profiles.
Quality of life scores varied significantly across the three self-management groups, except for emotional well-being.
Abstract
This study aimed to explore latent profiles of self-management ability in patients with cancer treated with immune checkpoint inhibitors, analyze each subgroup's characteristics, and determine the relationship between self-management and quality of life. This cross-sectional study included 393 patients treated with immune checkpoint inhibitors. The participants completed questionnaires containing sociodemographic information, the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM), the Cancer Patient Self-management Evaluation Scale, and the Medical Coping Modes Questionnaire. Latent profile analysis was used to examine potential latent groups of self-management. Multivariate logistic regression was used to analyze the sociodemographic variables in each profile. Kruskal-Wallis H-rank sum test was used to explore the relationships between self-management…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer survivorship and care · Pharmacy and Medical Practices · Neutropenia and Cancer Infections
